Better blood-thinner plan for heart artery stents
Part of Heart & circulation clinical trials.
This trial studies the best way to use blood-thinning medicines after placing a NeoVas™ dissolving stent in the heart. It may help prevent dangerous blood clots in the stent while reducing side effects like bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 18 or older, and if you can become pregnant, you’re not pregnant (and you agree to avoid pregnancy during the study).
- You have a heart artery narrowing or symptoms that suggest reduced blood flow, and your doctor says you need a stent procedure (PCI).
- Your planned stent spot is in a natural (non-bypass) heart artery with measurements that fit the study limits (length and width/diameter).
- You can take aspirin and clopidogrel every day during the study as required.
- Your stent plan and artery situation are suitable for the study (for example, no certain high-risk artery patterns like left main disease or visible clot).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether choosing blood thinners based on each person's needs works better than a standard approach after getting a heart stent. It aims to reduce risks like blood clots or bleeding.
This trial tests if a shorter, lower dose of two blood thinners is safe and effective for patients with a recent heart attack or unstable angina who are at high risk for bleeding. It uses a special stent that might allow for less medication.
This study looks at whether taking two blood thinners (aspirin and clopidogrel) helps people who have had a stent placed to open a long-term total blockage in a heart artery. If you had a successful procedure to open such a blockage and are able to take aspirin, this trial might be for you.
This trial tests whether patients who have had a heart attack or unstable angina and a stent placed with ultrasound guidance can safely stop one of their blood-thinning medicines early. It helps doctors find the best way to prevent future heart problems with fewer side effects.
This study tests whether taking a single blood-thinning medication (instead of two) after heart stent placement is safe and effective over the long term. If you've recovered well from a stent procedure, this trial may help determine the safest way to prevent future heart problems.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
Hear when a new Coronary Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.